Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vomiting 5Nausea 5Neoplasms 4Hematologic Neoplasms 4Anorexia 3Multiple Myeloma 2Breast Neoplasms 2Testicular Neoplasms 1Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1Prosthesis Failure 1Opioid-Related Disorders 1Nutrition Disorders 1Neoplasms, Plasma Cell 1Gynecologic Cancer 1Cachexia 1Advanced Cancer 1

Interventions

Megestrol Acetate 6Olanzapine 3Radiotherapy 1Melatonin 1Infliximab 1Etanercept 1Eicosapentaenoic Acid 1Docetaxel 1Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Anorexia × Olanzapine × Clear all
NCT04939090 2026-04-13

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
227 enrolled
Other hematologic neoplasm

Anorexia, Hematologic Neoplasms

NCT05243251 2024-10-03

Olanzapine Anorexia Cachexia

Cairo University

Phase 3 Completed
164 enrolled

Anorexia

NCT06517199 2024-07-24

Olanzapine for Cancer Related Anorexia-cachexia Syndrome

Mahidol University

Phase 3 Recruiting
138 enrolled

Anorexia, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡